title: Role of Rho kinase in sphingosine 1-phosphate-mediated endothelial and smooth muscle cell migration and differentiation.
abstract: The role of sphingosine 1-phosphate (S1P)-induced Rho kinase (ROCK) activation in the angiogenic responses of pulmonary artery-derived endothelial cells (PAEC) and smooth muscle cells (PASMC) was examined. S1P, a biologically active phospholipid that regulates angiogenesis, promoted PAEC chemotaxis and capillary morphogenesis; furthermore, this activity was unaltered by pretreatment with the pharmacological inhibitor of ROCK, H1152. In contrast, S1P (500 nM) significantly inhibited spontaneous PASMC chemotaxis and differentiation; however, this inhibition was eradicated upon H1152 pretreatment. Similarly, PASMCs transfected with ROCK II siRNA diminished S1P-induced inhibition of the development of multi-cellular structures. Analysis by RT-PCR identified the presence of S1P(1) and S1P(3) receptors on both PAECs and PASMCs, while S1P(2) receptor expression was confined to only PASMCs. Consistent with this observation, the S1P(1) and S1P(3) receptor antagonist, VPC23019, virtually abolished the S1P-initiated PAEC differentiation but did not impede the S1P-induced inhibition of PASMC differentiation. However, the S1P(2) receptor antagonist, JTE013, had no effect on S1P-mediated differentiation of PAECs but abolished the S1P-induced inhibition of PASMC function. Co-cultured endothelial and smooth muscle cells differentiated into "neovascular-like" networks, which were significantly inhibited by S1P. The inhibition of co-culture differentiation in both PAECs and PASMCs was negated by H1152 pretreatment. However, when smooth muscle cells were added to S1P-initiated endothelial cell networks, additional S1P treatment did not inhibit the cellular networks generated by these cells. In conclusion, S1P-induced PAEC angiogenic responses are regulated by S1P(1) and/or S1P(3) receptors independent of Rho kinase activation, whereas S1P(2) receptor-mediated curtailment of PASMC function by S1P.
authors.affiliation: Cellular Biochemistry Laboratory, Methodist Research Institute, Clarian Health Partners, Room E504, Indianapolis, IN, USA.
authors.forename: Kevin A
authors.initials: KA
authors.lastname: Harvey
authors.forename: Zachary
authors.initials: Z
authors.lastname: Welch
authors.forename: Daniel
authors.initials: D
authors.lastname: Sliva
authors.forename: Rafat A
authors.initials: RA
authors.lastname: Siddiqui
mesh_terms: D015153:Blotting, Western; D002454:Cell Differentiation / Q000187:drug effects*; D002460:Cell Line; D002465:Cell Movement / Q000187:drug effects*; D049109:Cell Proliferation; D002633:Chemotaxis; D018920:Coculture Techniques; D004730:Endothelium, Vascular / Q000166:cytology* / Q000378:metabolism; D006801:Humans; D007124:Immunoenzyme Techniques; D008246:Lysophospholipids / Q000494:pharmacology*; D009131:Muscle, Smooth, Vascular / Q000166:cytology* / Q000378:metabolism; D018919:Neovascularization, Physiologic; D010766:Phosphorylation; D011651:Pulmonary Artery / Q000166:cytology; D012333:RNA, Messenger / Q000235:genetics; D034741:RNA, Small Interfering / Q000494:pharmacology; D049349:Receptors, Lysosphingolipid / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000494:pharmacology; D054460:rho-Associated Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000502:physiology*
chemical_list: D008246:Lysophospholipids; D012333:RNA, Messenger; D034741:RNA, Small Interfering; D049349:Receptors, Lysosphingolipid; C060506:sphingosine 1-phosphate; D054460:rho-Associated Kinases; D013110:Sphingosine
references.citation: Circulation. 2007 Jan 30;115(4):501-8
references.pmid: 17242282
references.citation: Hypertension. 2007 Oct;50(4):792-8
references.pmid: 17785632
references.citation: Cell. 1999 Oct 29;99(3):301-12
references.pmid: 10555146
references.citation: Circulation. 1998 Feb 3;97(4):381-90
references.pmid: 9468212
references.citation: Angiogenesis. 2001;4(1):11-20
references.pmid: 11824373
references.citation: Am J Physiol Regul Integr Comp Physiol. 2007 Jan;292(1):R440-6
references.pmid: 16990495
references.citation: J Biol Chem. 2003 Nov 28;278(48):47654-9
references.pmid: 14500721
references.citation: J Biol Chem. 2002 Feb 22;277(8):6214-22
references.pmid: 11739394
references.citation: Mol Cell Neurosci. 1994 Jun;5(3):201-9
references.pmid: 8087418
references.citation: Am J Physiol Gastrointest Liver Physiol. 2006 Oct;291(4):G605-10
references.pmid: 16675745
references.citation: Circ Res. 2006 Oct 13;99(8):837-44
references.pmid: 16990566
references.citation: J Biol Chem. 2000 May 12;275(19):14281-6
references.pmid: 10799507
references.citation: J Biol Chem. 2005 Mar 18;280(11):9833-41
references.pmid: 15590668
references.citation: Am J Respir Cell Mol Biol. 2001 Jun;24(6):711-9
references.pmid: 11415936
references.citation: Nat Rev Mol Cell Biol. 2003 Jun;4(6):446-56
references.pmid: 12778124
references.citation: J Biol Chem. 1999 Dec 10;274(50):35343-50
references.pmid: 10585401
references.citation: Exp Cell Res. 2002 Apr 1;274(2):264-74
references.pmid: 11900487
references.citation: Eur J Clin Invest. 2007 Mar;37(3):171-9
references.pmid: 17359484
references.citation: J Lab Clin Med. 2002 Sep;140(3):188-98
references.pmid: 12271276
references.citation: Curr Pharm Des. 2006;12(5):575-87
references.pmid: 16472149
references.citation: Biochem Biophys Res Commun. 1996 Oct 14;227(2):608-14
references.pmid: 8878560
references.citation: Genomics. 1998 Oct 15;53(2):164-9
references.pmid: 9790765
references.citation: Biochim Biophys Acta. 2002 May 23;1582(1-3):72-80
references.pmid: 12069812
references.citation: J Cardiovasc Pharmacol. 2007 Aug;50(2):195-200
references.pmid: 17703136
references.citation: Biochem J. 2000 Jul 15;349(Pt 2):385-402
references.pmid: 10880336
references.citation: J Biol Chem. 2004 Oct 8;279(41):42422-30
references.pmid: 15292266
references.citation: J Biol Chem. 1992 Jun 5;267(16):10931-4
references.pmid: 1375931
references.citation: FASEB J. 2003 Oct;17(13):1931-3
references.pmid: 14519669
references.citation: Arterioscler Thromb Vasc Biol. 2003 Jan 1;23(1):69-75
references.pmid: 12524227
references.citation: J Cell Physiol. 2007 May;211(2):353-63
references.pmid: 17167780
references.citation: Pharmacol Ther. 2000 Nov;88(2):115-31
references.pmid: 11150592
references.citation: J Clin Invest. 2004 Feb;113(4):569-81
references.pmid: 14966566
references.citation: J Biol Chem. 1990 Jun 5;265(16):9308-13
references.pmid: 2160972
references.citation: Circ Res. 2007 Mar 30;100(6):923-9
references.pmid: 17332430
references.citation: Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1312-8
references.pmid: 17431187
references.citation: J Allergy Clin Immunol. 2009 Nov;124(5):933-41.e1-9
references.pmid: 19665772
references.citation: J Mol Med (Berl). 2002 Oct;80(10):629-38
references.pmid: 12395147
references.citation: Biochem J. 2000 Dec 15;352 Pt 3:809-15
references.pmid: 11104690
references.citation: Cancer Res. 2005 May 1;65(9):3788-95
references.pmid: 15867375
references.citation: Circ Res. 2004 Feb 20;94(3):385-93
references.pmid: 14670839
references.citation: FASEB J. 2000 Nov;14(14):2255-65
references.pmid: 11053247
references.citation: Am J Physiol Cell Physiol. 2004 May;286(5):C1130-8
references.pmid: 15075212
references.citation: Pharmacol Ther. 2002 Feb-Mar;93(2-3):225-32
references.pmid: 12191614
references.citation: J Immunol. 2003 Nov 15;171(10):5489-97
references.pmid: 14607955
references.citation: Biochem Biophys Res Commun. 2006 May 19;343(4):1038-44
references.pmid: 16574065